Stephen Mitchener - 02 Jun 2021 Form 4 Insider Report for Karyopharm Therapeutics Inc. (KPTI)

Role
SVP, Chief Business Officer
Signature
/s/ Nancy Smith as Attorney-in-Fact for Stephen Mitchener
Issuer symbol
KPTI
Transactions as of
02 Jun 2021
Transactions value $
-$4,905
Form type
4
Date filed
03 Jun 2021, 16:06
Previous filing
01 Jun 2021
Next filing
03 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KPTI Common Stock Sale -$4.91K -528 -17.6% $9.29* 2.47K 02 Jun 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units and does not represent a discretionary trade by the reporting person.